Further evidence for the association of GAL, GALR1 and NPY1R variants with opioid dependence

Pharmacogenomics. 2020 Aug;21(13):903-917. doi: 10.2217/pgs-2020-0045. Epub 2020 Aug 6.

Abstract

Aim: Heroin addiction is a chronic, relapsing disease that has genetic and environmental, including drug-induced, contributions. Stress influences the development of addictions. This study was conducted to determine if variants in stress-related genes are associated with opioid dependence (OD). Patients & methods: One hundred and twenty variants in 26 genes were analyzed in 597 Dutch subjects. Patients included 281 OD in methadone maintenance with or without heroin-assisted treatment and 316 controls. Results: Twelve SNPs in seven genes showed a nominally significant association with OD. Experiment-wise significant associations (p < 0.05) were found for three SNP pairs, through an interaction effect: NPY1R/GAL rs4691910/rs1893679, NPY1R/GAL rs4691910/rs3136541 and GALR1/GAL rs9807208/rs3136541. Conclusion: This study lends more evidence to previous reports of association of stress-related variants with heroin dependence.

Keywords: GAL; GALR1; NPY1R; case–control association study; opioid dependence.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Case-Control Studies
  • Female
  • Genetic Predisposition to Disease / genetics*
  • Genotype
  • Haplotypes / genetics
  • Heroin / therapeutic use
  • Heroin Dependence / genetics
  • Humans
  • Male
  • Methadone / therapeutic use
  • Opiate Substitution Treatment / methods
  • Opioid-Related Disorders / genetics*
  • Polymorphism, Single Nucleotide / genetics*
  • Receptor, Galanin, Type 1 / genetics*
  • Receptors, Neuropeptide Y / genetics*

Substances

  • Receptor, Galanin, Type 1
  • Receptors, Neuropeptide Y
  • neuropeptide Y-Y1 receptor
  • Heroin
  • Methadone